Characteristics of Children Receiving Proton Pump Inhibitors Continuously for Up to 11 Years Duration

Journal of Pediatrics

Volumn 150, Issue 3, 2007, Pages

  Hassall, Eric ^a   Kerr, Wendy ^a   El Serag, Hashem B ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; AGITATION; ARTICLE; BARRETT ESOPHAGUS; CHEMOTHERAPY INDUCED EMESIS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIARRHEA; DISEASE PREDISPOSITION; DRUG ERUPTION; DRUG SAFETY; ESOPHAGUS ATRESIA; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; IRRITABILITY; LONG TERM CARE; MAJOR CLINICAL STUDY; NAUSEA; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION;

EID: 33847303972     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.08.078     Document Type: Article

References (22)

1. Hassall E. Outcomes of fundoplication: causes for concern, newer options. Arch Dis Child 90 (2005) 1047-1052
2. Marks R.D., Richter J.E., Rizzo J., Koehler R.E., Spenney J.G., Mills T.P., et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 106 (1994) 907-915
3. Wang W.H., Huang J.Q., Zheng G.F., Xia H.H., Wong W.M., Lam S.K., et al. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol 11 (2005) 4067-4077
4. Huang J.Q., and Hunt R.H. pH, healing rate, and symptom relief in patients with GERD. Yale J Biol Med 72 (1999) 181-194
5. Hyman P.E., Garvey III T.Q., and Abrams C.E. Tolerance to intravenous ranitidine. J Pediatr 110 (1987) 794-796
6. Hyman P., and Hassall E. Marked basal gastric acid hypersecretion and peptic ulcer disease: medical management with combination H2-histamine receptor antagonist and anticholinergic. J Pediatr Gastroenterol Nutr 7 (1988) 57-63
7. Nwokolo C.U., Smith J.T., Gavey C., Sawyer A., and Pounder R.E. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 4 suppl 1 (1990) 29-45
8. Wilder-Smith C.H., Ernst T., Gennoni M., Zeyen B., Halter F., and Merki H.S. Tolerance to H2-receptor antagonists. Dig Dis Sci 35 (1990) 976-983
9. Gunasekaran T.S., and Hassall E. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 123 (1993) 148-154
10. Hassall E., Israel D.M., Shepherd R., Radke M., Dalväg A., Sköld B., and International Pediatric Omeprazole Study Group. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 137 (2000) 800-807
11. Tolia V., Ferry G., Gunasekaran T., Huang B., Keith R., and Book L. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 35 (2002) S308-S318
12. Gunasekaran T., Gupta S., Gremse D., Karol M., Pan W.-J., Chiu Y.-L., et al. Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy and tolerability. J Pediatric Gastroenterol Nutr 35 suppl 4 (2002) S327-S335
13. Fiedorek S., Tolia V., Huang B., Stolle J., Lee C., and Gremse D. Efficacy and safety of lansoprazole in adolescents with gastroesophageal reflux disease. J Pediatric Gastroenterol Nutr 40 (2005) 319-327
14. Klinkenberg-Knol E.C., Nelis F., Dent J., Snel P., Mitchell B., Prichard P., et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118 (2000) 661-669
15. Hassall E., and International Pediatric Omeprazole Study Group. Omeprazole for maintenance therapy of erosive esophagitis in children. [abstract]. Gastroenterology 118 (2000) A658
16. Raghunath A.S., O'Morain C., and McLoughlin R.C. The long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 22 suppl (2005) 55-63
17. Vandenplas Y., and Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 35 (2002) 119-136
18. Hassall E. Co-morbidities in childhood Barrett's esophagus. J Pediatr Gastroenterol Nutr 25 (1997) 255-260
19. Hassall E. Mistaking 'life' (as we know it) for 'disease'. [letter]. Am J Gastroenterol 101 (2006) 2434-2435
20. Kassem N.Y., Groen J.J., and Fraenkel M. Spinal deformities and oesophageal hiatus hernia. Lancet 49 (1965) 887-889
21. Darling D.B., Fisher J.H., and Gellis S.S. Hiatal hernia and gastroesophageal reflux in infants and children: analysis of the incidence in North American children. Pediatrics 54 (1974) 450-455
22. El-Serag H.B., Bailey N.R., Gilger M., and Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol 97 (2002) 1635-1639